Microstructural analysis of severe bone lesions in seven thalassemic patients treated with deferoxamine

被引:7
作者
De Sanctis, V
Savarino, L
Stea, S
Cervellati, M
Ciapetti, G
Tassinari, L
Pizzoferrato, A
机构
[1] Ist Ortoped Rizzoli, Dipartimento Putti, I-40136 Bologna, Italy
[2] Arcispedale S Anna, Dept Pediat & Adolescent Med, Ferrara, Italy
关键词
thalassemia; bone lesions; bone microstructure; X ray diffraction; microradiography; microhardness; deferoxamine;
D O I
10.1007/s002230001122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteochondrodystrophic lesions, mainly affecting long bone metaphyses, can be radiologically evident in homozygotic thalassemic patients treated with deferoxamine, and their incidence rate varies among authors. The clinical and radiological appearance of these lesions is described in the literature, but microstructural data are still lacking. The aim of our research was to evaluate the microstructure of five tibial biopsy specimens from thalassemic patients with bone lesions (5 cases out of 180 patients followed for the last 10 years, i.e., 2.8%) and two bone biopsy specimens from thalassemic patients with no radiological alteration of the long bones. As control, bone tissue taken from autoptic tibiae of two subjects with no skeletal pathology was used. Using microradiography and X-ray diffraction (XRD), we found a reduced and irregular mineralization of the bone (compared with controls) in thalassemic subjects. Bone tissue microhardness was also significantly reduced. Nevertheless, bone apatite lattice was unaltered and no 'foreign' crystallographic phase was recorded by XRD. In conclusion, all the patients shared a similar picture of abnormal bone, even with no radiological evidence of lesion.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 34 条
[21]  
OLIVIERI NF, 1992, AM J PEDIAT HEMATOL, V14, P48
[22]   VISUAL AND AUDITORY NEUROTOXICITY IN PATIENTS RECEIVING SUBCUTANEOUS DEFEROXAMINE INFUSIONS [J].
OLIVIERI, NF ;
BUNCIC, JR ;
CHEW, E ;
GALLANT, T ;
HARRISON, RV ;
KEENAN, N ;
LOGAN, W ;
MITCHELL, D ;
RICCI, G ;
SKARF, B ;
TAYLOR, M ;
FREEDMAN, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (14) :869-873
[23]   Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major [J].
Olivieri, NF ;
Brittenham, GM ;
McLaren, CE ;
Templeton, DM ;
Cameron, RG ;
McClelland, RA ;
Burt, AD ;
Fleming, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (07) :417-423
[24]  
ORZINCOLO C, 1992, SKELETAL RADIOL, V21, P39
[25]  
PRIEST ND, 1990, TRACE METALS FLUORID, P238
[26]   TRANSFUSION REQUIREMENTS AND EFFECTS IN PATIENTS WITH THALASSEMIA MAJOR [J].
REBULLA, P ;
MODELL, B .
LANCET, 1991, 337 (8736) :277-280
[27]   BONE-DISEASE IN CHILDREN WITH HOMOZYGOUS BETA-THALASSEMIA [J].
RIOJA, L ;
GIROT, R ;
GARABEDIAN, M ;
COURNOTWITMER, G .
BONE AND MINERAL, 1990, 8 (01) :69-86
[28]   Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion [J].
Roth, C ;
Pekrun, A ;
Bartz, M ;
Jarry, H ;
Eber, S ;
Lakomek, M ;
Schroter, W .
EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (10) :777-783
[29]   X-RAY-DIFFRACTION OF NEWLY FORMED BONE CLOSE TO ALUMINA-COATED OR HYDROXYAPATITE-COATED FEMORAL STEM [J].
SAVARINO, L ;
CENNI, E ;
STEA, S ;
DONATI, ME ;
PAGANETTO, G ;
MORONI, A ;
TONI, A ;
PIZZOFERRATO, A .
BIOMATERIALS, 1993, 14 (12) :900-905
[30]   PROFILE FITTING FOR QUANTITATIVE-ANALYSIS IN X-RAY-POWDER DIFFRACTION [J].
SCHREINER, WN ;
JENKINS, R .
ADVANCES IN X-RAY ANALYSIS, 1983, 26 :141-147